MGTX

MeiraGTx Holdings plc

Tremor tracks 2 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

MGTXMeiraGTx, LLC
0Calm
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Running, no new patientsPhase 2290 patientsMain results: Jun 2027
MGTXMeiraGTx, LLC
0Calm
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Invite-only sign-upPhase 2276 patientsMain results: Feb 2032

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

7 sales (0 not pre-planned) · 0 purchases

Giroux RichardCFO & COO · Oct 20, 2026Sold 56,000 sharesabout $557 thousand · pre-planned
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY · Oct 6, 2026Sold 27,659 sharesabout $294 thousand · pre-planned
Forbes AlexandriaPRESIDENT & CEO · Aug 18, 2026Sold 62,000 sharesabout $859 thousand · pre-planned
Giroux RichardCFO & COO · Jul 21, 2026Sold 56,000 sharesabout $701 thousand · pre-planned
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY · Jul 7, 2026Sold 2,547 sharesabout $35 thousand · pre-planned
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY · Jul 7, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.